Published in Medical Letter on the CDC and FDA, May 30th, 2004
This was one of five such awards made nationwide. MedQuest's consortium is led by its academic R&D partner, the University of Pittsburgh (Pennsylvania), under the leadership of Dr. Harvey Borovetz, chairman of bioengineering.
According to Borovetz, "The Pediatric VAD [PVAD] is designed to support newborns who are born with congenital heart defects and undergo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA